A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Allist Pharmaceuticals, Inc.
Jacobio Pharmaceuticals Co., Ltd.
Jacobio Pharmaceuticals Co., Ltd.
Erasca, Inc.
Revolution Medicines, Inc.
Shanghai Gopherwood Biotech Co., Ltd.
Revolution Medicines, Inc.